Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
Increased levels of phthalates in very low birth weight infants with septicemia and bronchopulmonary dysplasia
Abstract Very low birth weight infants (VLBW; birth weight<1500g) are exposed to potentially harmful phthalates from medical devices during their hospital stay. We measured urinary phthalate concentrations among hospitalized VLBW infants participating in a nutritional study. Possible associations between different phthalates and birth weight (BW), septicemia and bronchopulmonary dysplasia (BPD) were evaluated. Forty-six VLBW infants were enrolled in this randomized controlled nutritional study. The intervention group (n=24) received increased quantities of energy, protein, fat, essential fatty acids and vitamin A, as compared to the control group (n=22). The concentrations of 12 urinary phthalate metabolites were measured, using high-performance liquid chromatography coupled to tandem mass spectrometry, at 3 time points during the first 5weeks of life. During this study, the levels of di (2-ethylhexyl) phthalate (DEHP) metabolites decreased, whereas an increasing trend was seen regarding metabolites of di-iso-nonyl phthalate (DiNP). Significantly higher levels of phthalate metabolites were seen in infants with lower BW and those diagnosed with late onset septicemia or BPD. A significant positive correlation between the duration of respiratory support and DEHP metabolites was observed (p ≤0.01) at 2.9weeks of age. Birth weight was negatively associated with urinary phthalate metabolite concentrations. Infants with lower BW and those diagnosed with septicemia or BPD experienced prolonged exposure from medical equipment containing phthalates, with subsequent higher levels of phthalate metabolites detected. Clinical Trial Registration no.: NCT01103219.
Highlights Very low birth weight infants are exposed to phthalates during the hospital stay. Urinary phthalate metabolite concentrations were measured the first 5weeks of life. Phthalate exposure, from medical equipment in use, led to higher phthalate levels. Increased phthalate levels were seen among those with septicemia or lung disease. Phthalate exposure to preterm infants should be limited.
Increased levels of phthalates in very low birth weight infants with septicemia and bronchopulmonary dysplasia
Abstract Very low birth weight infants (VLBW; birth weight<1500g) are exposed to potentially harmful phthalates from medical devices during their hospital stay. We measured urinary phthalate concentrations among hospitalized VLBW infants participating in a nutritional study. Possible associations between different phthalates and birth weight (BW), septicemia and bronchopulmonary dysplasia (BPD) were evaluated. Forty-six VLBW infants were enrolled in this randomized controlled nutritional study. The intervention group (n=24) received increased quantities of energy, protein, fat, essential fatty acids and vitamin A, as compared to the control group (n=22). The concentrations of 12 urinary phthalate metabolites were measured, using high-performance liquid chromatography coupled to tandem mass spectrometry, at 3 time points during the first 5weeks of life. During this study, the levels of di (2-ethylhexyl) phthalate (DEHP) metabolites decreased, whereas an increasing trend was seen regarding metabolites of di-iso-nonyl phthalate (DiNP). Significantly higher levels of phthalate metabolites were seen in infants with lower BW and those diagnosed with late onset septicemia or BPD. A significant positive correlation between the duration of respiratory support and DEHP metabolites was observed (p ≤0.01) at 2.9weeks of age. Birth weight was negatively associated with urinary phthalate metabolite concentrations. Infants with lower BW and those diagnosed with septicemia or BPD experienced prolonged exposure from medical equipment containing phthalates, with subsequent higher levels of phthalate metabolites detected. Clinical Trial Registration no.: NCT01103219.
Highlights Very low birth weight infants are exposed to phthalates during the hospital stay. Urinary phthalate metabolite concentrations were measured the first 5weeks of life. Phthalate exposure, from medical equipment in use, led to higher phthalate levels. Increased phthalate levels were seen among those with septicemia or lung disease. Phthalate exposure to preterm infants should be limited.
Increased levels of phthalates in very low birth weight infants with septicemia and bronchopulmonary dysplasia
Strømmen, Kenneth (Autor:in) / Lyche, Jan Ludvig (Autor:in) / Blakstad, Elin Wahl (Autor:in) / Moltu, Sissel Jennifer (Autor:in) / Veierød, Marit Bragelien (Autor:in) / Almaas, Astrid Nylander (Autor:in) / Sakhi, Amrit Kaur (Autor:in) / Thomsen, Cathrine (Autor:in) / Nakstad, Britt (Autor:in) / Brække, Kristin (Autor:in)
Environmental International ; 89-90 ; 228-234
28.01.2016
7 pages
Aufsatz (Zeitschrift)
Elektronische Ressource
Englisch
BW , birth weight , BPD , bronchopulmonary dysplasia , CPAP , continuous positive airway pressure , DEHP , di(2-ethylhexyl) phthalate , DiNP , di-iso-nonyl phthalate , <hsp></hsp>∑ , <hsp></hsp>the sum of , GA , gestational age , LOQ , limit of quantitation , NICU , neonatal intensive care unit , VLBW , very low birth weight , Preterm infants , Exposure , Phthalate metabolites , Urine , Septicemia , Bronchopulmonary dysplasia
| British Library Online Contents | 2011
Significant Hypogammaglobulinemia in Very Low Birth Weight Infants
| DataCite | 1984
Interactions of phthalates with preterm birth
| Online Contents | 2015
Interactions of phthalates with preterm birth
| Elsevier | 2014